BSECompany Update3d ago · 12 Oct 2026, 03:02 pm
Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026
Godavari Drugs Ltd · 530317
✦ AI Summary
Godavari Drugs Ltd has submitted a compliance certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026, confirming compliance with the regulation.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern5/10
Regulatory Risk2/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Godavari Drugs Ltd - 530317 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Attachments (1)
📄pdf
Download →
85086a59-0706-4be2-ad75-15c84a39fe36.pdf
View document text
GODAVARI DRUGS LIMITED
Regd. Off.:‘Mayfair’, S.P. Road, Secunderabad - 500 003. TS, India.
Voice : +91-40-2784 9700 / 2784 2602 / 2784 4557
E-mail : info@godavaridrugs.com | Website : www.godavaridrugs.com
Date: 12.10.2026
The BSE Limited,
1st Floor, New Trading Wing,
Rotunda Building, P.J.Towers,
Dalal Street Fort,
Mumbai – 400 001
Dear Sir/Madam,
Sub: Certificate under Regulation 74(5) of SEBI (Depository and Participants) Regulations, 2018
Ref: Company Scrip Code: 530317
With reference to the above mentioned subject matter, please find enclosed herewith certificate issued by
CIL Securities Limited, Registrar and Share transfer Agent dated 12th October, 2026 confirming the
compliance of regulation 74 (5) of SEBI (Depository and Participants) Regulations, 2018 for the quarter
ended September 30, 2026
Kindly take the above information on records.
Thanking You,
for GODAVARI DRUGS LIMITED
Venkatesh Achanta
Company Secretary and Compliance Officer
Plant : A-6/2, MIDC, Nanded - 431 603. MS, India. E-mail : nnd@godavaridrugs.comCIN:L24230TG1987PLC008016